University Medical Center Hamburg-Eppendorf at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University Medical Center Hamburg-Eppendorf brings 23 presentations to ESGCT 2026 in Hamburg, its home city. Its work centres on AAV capsid engineering for cell-type-specific targeting, much of it aimed at kidney cells, and on engineered CAR and NK cells for blood cancers. Nanobody-displaying vectors and bispecific adaptors run through the targeting work.
| Organization | ESGCT 2026 Attendance |
|---|---|
University Medical Center Hamburg-Eppendorf Hamburg, Germany | |
University medical center in Hamburg, Germany, combining hospital care with medical research and teaching. | Chair Tue Oct 27 5:00pm–7:30pm SESSION 2a: AAVs/Non integrative vectors I - Basic Vectors and delivery (AAV, lentiviral, LNP) Talk Wed Oct 28 12:15pm–12:30pm A Lentiviral Reporter System for HLA-Restricted Viral CD8+ T-Cell Epitope Screening Vectors and delivery (AAV, lentiviral, LNP) Poster Wed Oct 28 1:30pm–3:30pm A nanobody‑based immunoassay for quantifying AAV8/9‑derived VLPs and engineered AAV vectors Poster Wed Oct 28 1:30pm–3:30pm AAV capsid engineering for podocyte-specific targeting Poster Wed Oct 28 1:30pm–3:30pm Bispecific nanobody-based adaptors boost cell-specific AAV transduction Poster Wed Oct 28 1:30pm–3:30pm Computational Protein Design of AAV Vectors for Kidney Cell-Type-Specific Targeting Poster Wed Oct 28 1:30pm–3:30pm Engineering Kidney-Specific AAV8 Vectors via Combined Rational Design and In Vivo Directed Evolution Poster Wed Oct 28 1:30pm–3:30pm Enhanced transient CAR expression in resting primary T cells through mRNA-LNP optimization Poster Wed Oct 28 1:30pm–3:30pm Evaluating the Therapeutic Potential of gamma delta T-cells and Blinatumomab in Extramedullary Leukemia Poster Wed Oct 28 1:30pm–3:30pm Normothermic ex vivo perfusion of solid human tumors for the selection of tumor-targeting AAV vectors Poster Wed Oct 28 1:30pm–3:30pm Shear Stress Modulates AAV-Mediated Gene Transfer in Human Endothelial Cells Poster Thu Oct 29 2:00pm–4:00pm Automated production of gene-edited CAR-T Cells for people living with HIV Poster Thu Oct 29 2:00pm–4:00pm Bringing the THUNDER: Highlighting Multiparatopic CAR Cells for Multiple Myeloma Treatment Poster Thu Oct 29 2:00pm–4:00pm CAR-NK cells targeting both CD45 and CD38 Poster Thu Oct 29 2:00pm–4:00pm Cross-species AAV targeting of glomerular endothelial cells with inducible expression control Poster Thu Oct 29 2:00pm–4:00pm Establishment and evaluation of a negative selection protocol to improve the purity of lentiviral vector-based libraries for single-cell analyses using beta-2,6-fructosyltransferase (sacB) from B. subtilis Poster Thu Oct 29 2:00pm–4:00pm In Vivo CRISPR Surfaceome Screening Identifies the Entry Receptor for Glomerular Endothelial-Targeted AAV Vectors. Poster Thu Oct 29 2:00pm–4:00pm Nanobody-displaying AAV vectors that target glioblastoma brain tumors Poster Thu Oct 29 2:00pm–4:00pm Novel Bispecific T- and NK-Cell Engagers for the Depletion of IgE-Expressing Cells in Allergy Poster Thu Oct 29 2:00pm–4:00pm Optimization of ex vivo culture and lentiviral transduction conditions for murine Fanconi anemia hematopoietic stem and progenitor cells Poster Thu Oct 29 2:00pm–4:00pm Specific transduction of skeletal muscles and heart in vivo with Nanobody-displaying AAV Poster Thu Oct 29 2:00pm–4:00pm Twice as nice: Biparatopic CD229-specific VHH-based heavy-chain antibodies for the treatment of multiple myeloma Cancer gene and cell therapy Poster Thu Oct 29 2:00pm–4:00pm Uncovering tumor-intrinsic immune evasion in neuroblastoma using 3D spheroids Talk Thu Oct 29 5:00pm–6:00pm Discovery and initial characterization of a missense mutation (G1312A; E438K) in a signalling motif of the axi-cel and brexu-cel CD19-CARs present at high frequency in probably all clinical products Cell therapies and CAR-TCancer gene and cell therapy |
Instantly find 20 buyers from University Medical Center Hamburg-Eppendorf
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction